Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- FDA Advisory Committee Process Changes
- The Food and Drug Administration FDA announced on November 15 steps to strengthen its advisory committee processes in response to recent recommendations from the Institute of Medicine. The measures include proposed new guidance or procedures on advisoryThe Food and Drug Administration FDA announced on November 15 steps to strengthen its...
- Research articles 2008-01-01
- FDA not utilizing its advisory system
- PUBLIC CITIZEN SAYS an analysis of FDA advisory committee meetings between January 1997 and last July found the agency is making suhoptimum use of its advisory committee system. Writing in the December 23 issue of Lancet. Public Citizen said a declining minority of products up for approval face advisory committees,...
- Research articles 2007-02-01
- Watchdog Group Calls for FDA Advisory Committee Member's Resignation
- GAITHERSBURG, Md., Feb. 9 /U.S. Newswire/ -- A citizens group called for the resignation of psychologist Louis A. Morris from the FDA's Advisory Committee on Drug Safety and Risk Management today. This came as the advisory committee met to discuss suddenGAITHERSBURG, Md., Feb. 9 /U.S. Newswire/ -- A citizens...
- Research articles 2006-02-09
- FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation
- WOODCLIFF LAKE, N.J., May 7 /PRNewswire/ -- Eisai Corporation of North America and its U.S. subsidiary, MGI PHARMA, INC., today announced that the U.S. Food and Drug Administration FDA Advisory Committee on Anesthetic and Life Support Drugs ALSDAC has voted 6 to 3 in favor with one abstention of...
- Research articles 2008-05-07
- Nektar Reports That FDA Advisory Committee Recommends Approval of Exubera® for Use in Adults with Type 1 and Type 2 Diabetes
- SAN CARLOS, Calif. -- Nektar Therapeutics (Nasdaq:NKTR) today reported that Pfizer Inc and the sanofi-aventis Group said that a U.S. Food and Drug Administration FDA advisory committee panel has recommended the approval of ExuberaR (insulin rDNA origin powder for oral inhalation), an inhaleable, rapid-acting, dry powder insulin for the treatment...
- Research articles 2005-09-08
- Patients Urge Implementation of FDA Advisory Committee Recommendation for Public Health Emergency; HHS Blood Safety and Availability Advisory Committee Stresses Need for Immediate Action to Protect Patients' Lives
- TOWSON, Md. & WASHINGTON -- The Immune Deficiency Foundation, The Neuropathy Association and The Myositis Association have united to urge the U.S. Secretary of Health and Human Services Secretary Mike Leavitt to heed a recent recommendation to declare a public health emergency. The recommendation was approved unanimously on May 16...
- Research articles 2005-06-02
- Lev Announces FDA Advisory Committee Unanimously Recommends Approval of Cinryze™ for Hereditary Angioedema
- Company to Host Conference Call on Monday, May 5 at 8:30 am EST
- Research articles 2008-05-02
- Elan Announces the Suspension of Trading of Its Shares Commencing March 7, 2006 For Up to Two Days; Suspension of Trading Due to Two Day FDA Advisory Committee Meeting to Review Tysabri
- DUBLIN, Ireland -- Elan Corporation, plc today announced it has agreed with the Irish Stock Exchange ISE, the Financial Services Authority in the United Kingdom and the New York Stock Exchange NYSE to suspend trading of its securities ADRs and ordinary shares during the scheduled U.S. Food and Drug Administration...
- Research articles 2006-02-28
- Takeda Responds to the FDA Advisory Committee Recommendation.
- LONDON, July 31 /PRNewswire/ -- LONDON, July 31 /PRNewswire/ --
- Research articles 2007-07-31
- FDA Advisory Committee Recommends Licensure of New Pediatric Combination Vaccine.
- BETHESDA, Maryland, January 25 /PRNewswire/ -- BETHESDA, Maryland, January 25 /PRNewswire/ --
- Research articles 2007-01-25
- Advanced Cell Technology's Executive Invited to Present Today to FDA Advisory Committee on Cellular Tissue Therapies
- ALAMEDA, Calif. -- Advanced Cell Technology, Inc. (OTCBB: ACTC) announced today that Jonathan H. Dinsmore Ph.D., Senior Vice President - Regulatory and Clinical, has been invited to present to the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research Advisory Committee on Cellular, Tissue and Gene Therapies. Dr....
- Research articles 2008-04-10
- Advisory info may jeopardize trade secrets
- Public disclosure of information packages provided to advisory committee members prior to a panel meeting could jeopardize trade secret and confidential/ commercial information, industry argues in recently released comments to the FDA. The comments are in response to an agency draft guidance entitled Disclosing Information Provided to Advisory Committees ...,...
- Research articles 2000-06-01
- FDA Advisory Committee Recommends Approval of Adeza's NDA for Gestiva to Prevent Preterm Birth
- SUNNYVALE, Calif. -- Adeza (NASDAQ:ADZA) today announced that the Reproductive Health Drugs Advisory Committee to the U.S. Food and Drug Administration FDA recommended by a majority vote that the data presented by Adeza in its New Drug Application NDA for GestivaTM support efficacy in preventing preterm birth prior to 35...
- Research articles 2006-08-30
- FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia.
- PHILADELPHIA, October 17 /PRNewswire/ -- PHILADELPHIA, October 17 /PRNewswire/ --
- Research articles 2007-10-16
- NDA rejections don't signal tougher reviews
- Could a recent spate of drug "not approvable" decisions by the Food and Drug Administration FDA and its expert advisory committees signal a more cautious agency? Not at all, FDA director of drugs Janet Woodcock told Dow Jones Newswire on August 2. While the agency does not track favorable or...
- Research articles 2001-09-01
- FDA Advisory Committee Unanimously Recommends Reintroduction of TYSABRI® for the Treatment of Relapsing Forms of Multiple Sclerosis
- GAITHERSBURG, Md. -- Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced today that the Peripheral and Central Nervous System Drugs Advisory Committee of the U.S. Food and Drug Administration FDA voted unanimously to recommend reintroduction of TYSABRIR natalizumab as a treatment for relapsing forms of multiple sclerosis...
- Research articles 2006-03-08
- Rep. Slaughter Urges FDA to Heed Its Scientific Advisory Committee's Recommendation on Drug Used to Treat Life-Threatening Infections
- To: POLITICAL+ EDITORSTo: POLITICAL+ EDITORS
- Research articles 2007-01-11
- FDA Advisory Committee Recommends Against Approval for Merck's NDA for ARCOXIA®
- WHITEHOUSE STATION, N.J. -- Please replace the release with the following corrected version due to multiple revisions.
- Research articles 2007-04-12
- Food advisory committee meeting.(Brief Article)
- FDA's Food Advisory Committee will hold a public meeting on Dec. 10 and 11 in Washington DC. The purpose of the meeting is to review reports of the Dietary Supplements, Additives and Ingredients, Food Biotechnology, Contaminants and Natural Toxicants FDA's Food Advisory Committee will hold a...
- Research articles 2003-11-24
- FDA Advisory Committee recommends approval for ZINECARD®
- DUBLIN, Ohio--BUSINESS WIRE--Dec. 12, 1994--The U.S. Food and Drug Administration Oncologic Advisory Committee met today to review data concerning ZINECARDR dexrazoxane for injection sponsored by Pharmacia Inc.
- Research articles 1994-12-12
- << Previous
- page 1 of 7
- Next >>